Lung Cancer Clinical Trials

Showing 781-800 of 4,288 trials

A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

NCT05034926

The purpose of this observational study is to estimate the overall survival (OS) rates in the overall study population treated with nivolumab in the second and third line setting in real world clinical practice in Greece and Cyprus. The study is descriptive in nature and is not planned to reject or affirm any formal statistical hypothesis.

Non-Small Cell Lung Cancer

Bristol-Myers Squibb212 participantsStarted Oct 2020

Stróvolos, Cyprus • Athens, Greece

COMPLETEDEARLY Phase 1

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

NCT02914899

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.

Lung Cancer ScreeningCurrent or Past Cigarette Smoker

Memorial Sloan Kettering Cancer Center99 participantsStarted Aug 2016

New York, New York, United States

A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Related Searches

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

The INSPIRE-Lung Study

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)

Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial

Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer

A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Involvement of General Practitioners in Lung Cancer Screening

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients

Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC

Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent

PALACE: Cemiplimab Trial According to ctDNA Levels

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy